Traditional manual testing of ventilator performance is labor-intensive, time-consuming, and prone to errors in data recording, making it difficult to meet the current demands for testing efficiency in the development and manufacturing of ventilators. Therefore, in this study we designed an automated testing system for essential performance parameters of ventilators. The system mainly comprises a ventilator airflow analyzer, an automated switch module for simulated lungs, and a test control platform. Under the control of testing software, this system can perform automated tests of critical performance parameters of ventilators and generate a final test report. To validate the effectiveness of the designed system, tests were conducted on two different brands of ventilators under four different operating conditions, comparing tidal volume, oxygen concentration, and positive end expiratory pressure accuracy using both the automated testing system and traditional manual methods. Bland-Altman statistical analysis indicated good consistency between the accuracy of automated tests and manual tests for all respiratory parameters. In terms of testing efficiency, the automated testing system required approximately one-third of the time needed for manual testing. These results demonstrate that the designed automated testing system provides a novel approach and means for quality inspection and measurement calibration of ventilators, showing broad application prospects.
Ventilators, Mechanical/standards* ; Equipment Design ; Humans ; Automation

Objective:To observe the effects of sorafenib on the lesions and vascular growth factors in the mouse model of hepatic alveolar echinococcosis.Methods:One hundred healthy female Kunming mice weighing (20±4) g were used to establish a model of alveolar echinococcosis infection by intraperitoneal injection of alveolar echinococcosis protoscoleces. After 6 weeks of feeding, the rats were divided into 5 groups, 15 rats in each group, which were given warm saline, albendazole (100 mg/kg), and sorafenib at high-dose (100 mg/kg), middle-dose (50 mg/kg) and low-dose (30 mg/kg) by gavage for 6 weeks, respectively. Eyeball blood and hepatic alveolar echinococcosis tissue were collected from the mice after the last administration, and the body weight of the mice and the lesion weight were weighed. The concentrations and expression levels of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor-A (VEGF-A) and vascular endothelial growth factor receptor-2 (VEGFR-2) in serum and lesion tissues were detected by enzyme-linked immunosorbent assay (ELISA) and Western blotting.Results:There was no statistically significant difference in the body weight of mice among the saline group, albendazole group and low-dose, medium-dose and high-dose sorafenib groups ( F=0.43, P=0.784). The ratios of lesion weight to body weight in the above groups were (0.057±0.009), (0.031±0.005), (0.033±0.005), (0.031±0.005), and (0.031±0.005), respectively. The saline group had a higher ratio than the other four groups, and the differences were statistically significant (all P<0.05). The relative expression levels of HIF-1α, VEGF-A, VEGFR-2, CD31 and CD34 detected by Western blotting in the saline group were all higher than those in the albendazole group and the high-dose, medium-dose and low-dose sorafenib groups, and the differences were statistically significant (all P<0.05). The relative expression levels of the above proteins in the medium-dose and high-dose sorafenib groups were lower than those in the albendazole group, and the relative expression levels of the above proteins in the high-dose sorafenib group were also lower than those in the medium-dose sorafenib group, and the differences were statistically significant (all P<0.05). The concentration levels of HIF-1α, VEGF-A and VEGFR-2 in serum of mice in each group detected by ELISA were consistent with those detected by Western blotting. Conclusion:Sorafenib inhibits the proliferation of alveolar echinococcosis in mice by suppressing the expression of angiogenic factors in alveolar echinococcosis lesions.

Objective Based on data mining,the medication patterns and characteristics of traditional Chinese medicine compound in treatment of radiotherapy-induced oral mucositis(RIOM)were studied to provide references for clinical diagnosis and treatment.Methods Search for relevant literatures on the intervention of traditional Chinese medicine in RIOM published in databases such as CNKI,VIP,and Wanfang Data Knowledge Service Platform from their establishment to December 6,2024.High-frequency drug statistics,association rules,systematic clustering and complex network analysis were conducted using Excel 2010,SPSS Modeler 18.0 and Origin 2024 software.Results A total of 70 prescriptions involving 154 herbs were selected.There were 16 herbs with a frequency≥ 12,and the top 10 were Maidong,Shengdihuang,Shenggancao,Xuanshen,Jinyinhua,Beishashen,Lianqiao,Jiegeng,Taizishen,Fuling.The four qi were mainly cold,while the five flavors were mainly sweet and bitter.The channel tropism were most concentrated in lung meridian,stomach meridian,and heart meridian.Association rule analysis identified 10 commonly used drug pairs,systematic clustering yielded 5 novel drug combinations,and complex network analysis results were consistent with systematic clustering.Conclusion Traditional Chinese medicine treatment for RIOM mainly focuses on clearing heat and removing toxicity,supplement qi and nourish yin,while also promoting production of fluid,promoting blood circulation for removing blood stasis,and dispersing pathogenic factors.The new formulas obtained from data mining,such as Maidong,Beishashen,Yuzhu,Shihu,Tiandong,Jinyinhua,Lianqiao,Shenggancao,can provide good clinical reference.

In recent years, the development of next-generation sequencing has brought a broad prospect for the investigation of the pathogenesis, signal pathways, and biomarkers of skin diseases. Due to the advantages in the recognition of nucleic acid sequences, next-generation sequencing can recognize not only microorganisms on normal skin surfaces, but also rare pathogens which were difficult to be identified before. This review summarizes the application of next-generation sequencing in non-hereditary dermatoses, aiming to explore their pathogenesis and improve their diagnosis.

Objective To analyze the influencing factors of chronic liver failure in patients with primary hepatic carcinoma(PHC)before intervention,and to establish and evaluate a nomogram risk prediction model.Methods A retrospective analysis was conducted by collecting general data and clinical test data within 24 hours of admission for PHC patients.Univariate analysis and Lasso regression were used for variable selection,followed by multivariate logistic regression analysis to identify independent influencing factors for CLF before PHC intervention,leading to the establishment of a nomogram risk prediction model.The model was evaluated using the Hosmer-Lemeshow test,receiver operating characteristic(ROC)curve,calibration curve,clinical decision curve,and clinical impact curve.Result A total of 353 cases of PHC patients were collected,including 153 cases in the liver failure group and 200 cases in the non-liver failure group,with a prevalence rate of 43.3％.Variables selected by Lasso regression included gastrointestinal bleeding,prothrombin time(PT),albumin(ALB),total bilirubin(TBIL),and gamma glutamyl transferase(GGT).Multivariate logistic regression analysis showed that gastrointestinal bleeding(OR=13.549,95％CI:2.899～63.322,P=0.001),PT(OR=1.599,95％CI:1.282～1.995,P＜0.001),TBIL(OR=1.016,95％CI:1.006～1.025,P=0.002),and GGT(OR=1.002,95％CI:1.000～1.003,P=0.028)were independent risk factors for chronic liver failure prior to PHC intervention,leading to the establishment of a nomogram risk prediction model.The Hosmer Lemeshow test showed that the model had a good fit(x2=6.152,P＞0.05);the area under ROC was 0.902(0.869-0.934),with a sensitivity of 80.4％and a specificity of 87.5％.The calibration curve indicated that the model predicts chronic liver failure prior to PHC intervention with good consistency.Clinical decision curve analysis and clinical impact curve analysis showed that the model has good clinical utility within a certain threshold range.Conclusion Gastrointestinal bleeding,PT ≥16.05s,TBIL≥37.80 mmol/L,and GGT≥ 99.00 U/L are independent risk factors for the occurrence of chronic liver failure before PHC intervention.The established nomogram risk prediction model has certain clinical application value in predicting the risk of chronic liver failure before PHC intervention.

Local anesthetics (LAs), such as articaine (AT), exhibit limited efficacy in inflammatory environments, which constitutes a significant limitation in their clinical application within oral medicine. In our prior research, we developed AT-17, which demonstrated effective properties in chronic inflammatory conditions and appears to function as a novel oral LA that could address this challenge. In the present study, we further elucidated the beneficial effects of AT-17 in acute inflammation, particularly in oral acute inflammation, where mitochondrial-related apoptosis played a crucial role. Our findings indicated that AT-17 effectively inhibited lipopolysaccharide (LPS)-induced nerve cell apoptosis by ameliorating mitochondrial dysfunction in vitro. This process involved the inhibition of mitochondrial reactive oxygen species (mtROS) production and the subsequent activation of the NRF2 pathway. Most notably, improvements in mitochondria-related apoptosis were key contributors to AT-17's inhibition of voltage-gated sodium channels. Additionally, AT-17 was shown to reduce mtROS production in nerve cells through the Na⁺/NCLX/ETC signaling axis. In conclusion, we have developed a novel local anesthetic that exhibits pronounced anesthetic functionality under inflammatory conditions by enhancing mitochondria-related apoptosis. This advancement holds considerable promise for future drug development and deepening our understanding of the underlying mechanisms of action.

[Purpose]To analyze the cost-effectiveness of endoscopic screening for upper gastroin-testinal cancer in Yangcheng County of Shanxi Province.[Methods]People aged from 40 to 69 who participated in upper gastrointestinal cancer screening in Yangcheng County in 2018 were se-lected as the study subjects to participate in upper gastrointestinal cancer screening in 2018,and endoscopic examination with iodine staining and indicative biopsy were performed for screening.The detection rates of precancerous lesions and upper gastrointestinal malignancies,and early di-agnosis rates were calculated,and compared among different groups.The data of screening cost were collected;and the per capita screening cost,the average cost of early case detection and ear-ly detection cost index(EDCI)were calculated.[Results]Among 2 950 subjects undergoing en-doscopy,pathological biopsy was completed in 2 073 cases(70.27％),374 cases of precancerous le-sions(12.68％)and 52 cases of malignancies(1.76％)were detected,among which 17 cases were up-per gastrointestinal cancer with a detection rate of 0.58％,there were 44 early cases with an early diagnosis rate of 84.62％.The detection rate of precancerous lesions and positive cases in men was higher than that of women,but the early diagnosis rate of upper gastrointestinal cancer was lower than that of women;the detection rate of positive cases and digestive tract cancer of 50 years and above were higher than those of people aged 40 to 49.The cost of screening for one positive lesion was 25 528.85 CNY,the cost of screening for one early case was 30 170.46 CNY.The EDCI was 0.52,indicating a good cost-effective value.[Conclusion]The study shows that the early diagnosis and early treatment screening program of upper gastrointestinal cancer has achieved remarkable re-sults in Yangcheng County.The follow-up screening work should focus on men and people over 50 years old,and strengthen the publicity of upper gastrointestinal screening for cancer.

Objective:To compare the clinical manifestations of congenital cataracts across different age groups and investigate the clinical characteristics and risk factors associated with infantile congenital cataracts.Methods:A cross-sectional study was conducted.The medical records of 156 children aged under 6 years diagnosed with congenital cataracts at Peking University People's Hospital were collected.Participants were divided into two groups, the infantile group (107 cases) and the non-infantile group (49 cases) according to whether the first diagnosis was ≤12 months.Clinical presentations were compared between the two groups.Risk factors for infantile congenital cataracts was analyzed by multivariate logistic regression.This study adhered to the Declaration of Helsinki, and the study protocol was reviewed and approved by the Ethics Review Committee of Peking University People's Hospital (No.2023PHB150-001).Results:The incidence rate of both eyes in the infantile group was 80.37%(86/107), which was significantly higher than 48.98%(24/49) in the non-infantile group ( χ2=15.931, P<0.001).The proportion of chief complaint of leucocoria in the infantile group was 87.85%(94/107), which was significantly higher than 44.90%(22/49) in the non-infantile group ( χ2=32.521, P<0.001).There were significant differences in the proportion of gestational age, birth weight, and neonatal oxygen therapy between the two groups ( χ2=13.300, 8.363, 13.283; all P<0.05).Multivariate logistic regression analysis showed that preterm birth ( OR=2.901, P=0.026), low birth weight ( OR=3.316, P=0.047), history of oxygen inhalation ( OR=3.040, P=0.012), and a family history of cataracts ( OR=14.224, P=0.013) were the main risk factors for congenital cataracts in infancy.The age of first diagnosis in children diagnosed with congenital cataracts through hospital screening was younger than that through parent observation ( Z=1 416.00, P=0.045). Conclusions:Infantile congenital cataracts predominantly present in both eyes with leukocoria as main manifestation.Preterm birth, low birth weight, neonatal oxygen exposure, and family history of cataracts are risk factors for infantile congenital cataracts.Systematic hospital screening is essential for the early detection of congenital cataracts in infants.

Lens injury is an important etiological factor in the reduction of visual function following ocular trauma.Currently, there are no clear standards for the classification of lens injury, and comprehensive diagnostic tools are lacking.This deficiency leads to numerous controversies and challenges in critical areas, such as diagnosis and preoperative evalution, timing of surgery, surgical strategy, and assessment of postoperative prognosis.Tomographic imaging technology, such as computed tomography, magnetic resonance imaging, optical coherence tomography, has introduced a new dimension to the evaluation of lens injury, which is crucial for assessing the transparency, texture, location, morphology, and integrity of the lens, as well as the zonules and nearby intraocular structures.However, the use of tomographic imaging technology is somewhat limited due to the limitations of relying on a single method.With the ongoing advancement of imaging technologies and the rapid development of big data and artificial intelligence, tomographic imaging will become an increasingly essential tool in the future management of lens injury.Our expert group reviewed the epidemiological characteristics and classification of lens injury and the major challenges currently faced in the diagnosis and treatment of lens injury, and provided expert recommendations mainly focusing on the application, shortcomings and limitations of current tomographic imaging technology in the diagnosis and treatment of lens injury, and future development directions.

In recent years, the development of next-generation sequencing has brought a broad prospect for the investigation of the pathogenesis, signal pathways, and biomarkers of skin diseases. Due to the advantages in the recognition of nucleic acid sequences, next-generation sequencing can recognize not only microorganisms on normal skin surfaces, but also rare pathogens which were difficult to be identified before. This review summarizes the application of next-generation sequencing in non-hereditary dermatoses, aiming to explore their pathogenesis and improve their diagnosis.